| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0173-0526-00 | 0173-0526 | HUMAN PRESCRIPTION DRUG | LAMICTAL | lamotrigine | TABLET, FOR SUSPENSION | ORAL | 19980904 | N/A | NDA | NDA020764 | GlaxoSmithKline LLC | LAMOTRIGINE | 5 mg/1 | 100 TABLET, FOR SUSPENSION in 1 BOTTLE (0173-0526-00) |
| 0173-0527-00 | 0173-0527 | HUMAN PRESCRIPTION DRUG | LAMICTAL | lamotrigine | TABLET, FOR SUSPENSION | ORAL | 19980903 | N/A | NDA | NDA020764 | GlaxoSmithKline LLC | LAMOTRIGINE | 25 mg/1 | 100 TABLET, FOR SUSPENSION in 1 BOTTLE (0173-0527-00) |
| 0173-0699-00 | 0173-0699 | HUMAN PRESCRIPTION DRUG | LAMICTAL | lamotrigine | TABLET, FOR SUSPENSION | ORAL | 20001012 | N/A | NDA | NDA020764 | GlaxoSmithKline LLC | LAMOTRIGINE | 2 mg/1 | 30 TABLET, FOR SUSPENSION in 1 BOTTLE (0173-0699-00) |
| 0173-0699-02 | 0173-0699 | HUMAN PRESCRIPTION DRUG | LAMICTAL | lamotrigine | TABLET, FOR SUSPENSION | ORAL | 20001012 | N/A | NDA | NDA020764 | GlaxoSmithKline LLC | LAMOTRIGINE | 2 mg/1 | 30 TABLET, FOR SUSPENSION in 1 BOTTLE (0173-0699-02) |